NTT Research and Harvard Collaborate on Cardiovascular Bio Digital Twin
Retrieved on:
Wednesday, November 16, 2022
Research, Technology, Health Technology, Cardiology, Biotechnology, University, Health, Science, Education, Artificial Intelligence, Cell, Sekisui Chemical, Physics, Disease, CV, DBG, Medicine, Technical University of Munich, Name, Institute of technology, Comenius University Faculty of Mathematics, Physics and Informatics, Research, IPS, Photonics, Cryptography, MEI, University, Neuroscience, Hope, PHI, Silicon, TUM, Electrode, Ireland national cerebral palsy football team, Munich School, Kyoto University, Nippon Telegraph and Telephone, Harvard John A. Paulson School of Engineering and Applied Sciences, Applied science, Bachelor of Engineering, MS, Physiology, Therapy, NCVC, CIS, NTT, SEAS, Information, Tissue, Harvard University, Organization, Electrophysiology, Heart, BS, Medical device, Mobile phone, Chemistry, Engineering, Informatics
NTT Research scientists will work with the Disease Biophysics Group (DBG) at SEAS to engineer a model of the human heart, elucidate fundamental laws of muscular pumps, and apply lessons learned to a cardiovascular (CV) bio digital twin model.
Key Points:
- NTT Research scientists will work with the Disease Biophysics Group (DBG) at SEAS to engineer a model of the human heart, elucidate fundamental laws of muscular pumps, and apply lessons learned to a cardiovascular (CV) bio digital twin model.
- His groups long-term goal of engineering a living, functional heart maps well with our CV bio digital twin initiative.
- I am honored to be joining the MEI Lab team at NTT Research while continuing complementary work at Harvard, Mr. Ishii said.
- NTT Research is part of NTT, a global technology and business solutions provider with an annual R&D budget of $3.6 billion.